Retosiban

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Obstetric Labour, Premature

Phase 1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)

CompletedNCT01867996

GlaxoSmithKlineObstetric Labour, Premature

Start: 2013-06-11End: 2013-09-26Updated: 2017-05-11

Phase 3

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

CompletedNCT02292784

GlaxoSmithKlineObstetric Labour, Premature

Start: 2015-06-01End: 2019-09-02Updated: 2020-07-09

A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

TerminatedNCT02292771

GlaxoSmithKlineObstetric Labour, Premature

Start: 2015-03-16End: 2017-08-25Updated: 2020-07-29

Related Papers

Effect of Efavirenz on the Pharmacokinetics of SHR6390 in Healthy Volunteers

Drug Design Development and Therapy2024-07-013 citations